国际指南与共识对糖皮质激素治疗类风湿关节炎的立场:系统综述
该系统综述检索Ovid Embase、PubMed Medline和Cochrane Library中类风湿关节炎药物治疗指南,用AGREE II工具评价质量并提取糖皮质激素相关内容。所有指南均认为低剂量短疗程糖皮质激素是合适选择,但多数推荐模糊,命名不统一,指南质量存在缺陷。
要点
- 所有指南认同低剂量短疗程糖皮质激素是RA治疗的合适选择。
- 多数推荐因可靠详细证据缺乏而模糊,重要方面被部分或完全忽视。
- 糖皮质激素治疗的命名不统一,指南质量评价存在缺陷。
核心结论
- 当前RA管理中糖皮质激素使用推荐不理想,需更严格评估剂量、时机和疗程,并统一现有命名。
研究设计与样本
- 系统文献综述,检索Ovid Embase、PubMed Medline和Cochrane Library中的RA药物治疗指南,用AGREE II工具评价质量并提取糖皮质激素相关信息。
主要发现
- 所有指南同意糖皮质激素尤其低剂量短疗程是RA治疗的合适选择。
- 许多推荐因可靠详细证据稀缺而模糊,糖皮质激素治疗的重要方面被部分或完全忽视。
- 现有命名未统一使用,质量评价显示许多文章在糖皮质激素特异性推荐和指南总体质量上存在缺陷。
临床怎么用
- 临床可依据指南将低剂量短疗程糖皮质激素作为RA治疗的合适选择,但需注意推荐模糊之处。
局限性
- 可靠且详细的证据稀缺,导致许多推荐模糊。
- 现有命名不统一,影响推荐的一致性。
- 质量评价显示许多文章存在缺陷,涉及糖皮质激素特异性推荐和指南总体质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the perception of the current role of systemic glucocorticoids in the management of rheumatoid arthritis (RA) by examining their importance and the current level of evidence in recent guidelines, and to identify open questions to be addressed in future guidelines and research projects. METHODS: We conducted a systematic literature review using the databases Ovid Embase, PubMed Medline, and Cochrane Library for guidelines on the pharmacologic treatment of RA. Retrieved articles were evaluated regarding their quality using the Appraisal of Guidelines for Research and Evaluation II tool and scrutinized for all relevant information concerning the use of glucocorticoids. RESULTS: All guidelines agree that glucocorticoids, especially if given at low doses and for a short duration, are an appropriate option in the treatment of RA. However, many recommendations remain vague, as reliable and detailed evidence is scarce. Important aspects of glucocorticoid therapy are partially or completely neglected, and the existing nomenclature is not used uniformly. Quality evaluation revealed flaws in many articles, concerning not only glucocorticoid-specific recommendations but also guideline quality in general. CONCLUSION: Current recommendations for use of glucocorticoids in the management of RA are suboptimal. More rigorous evaluation of doses, timing, and duration of their use is needed. Existing nomenclature on glucocorticoid therapy should be used uniformly.
引用
- Palmowski Y, Buttgereit T, Dejaco C, et al. "Official View" on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements. Arthritis Care Res (Hoboken). 2017. PMID: 28029750. doi:10.1002/acr.23185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。